Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001104659-25-090207

Chairperson & CEO sold 8,000 shares at an average $400.93 ($3,207,436)

  • Chairperson & CEO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-12 Exercise or conversion : show line 1 in the form 10b5-1 +4,000 $120.26 $481,040 4,130 D
2025-09-12 Sale : show line 2 in the form 10b5-1 −1,000 $402.21 $402,210 3,130 D
2025-09-12 Sale : show line 3 in the form 10b5-1 −1,000 $403.91 $403,910 2,130 D
2025-09-12 Sale : show line 4 in the form 10b5-1 −2,000 $404.89 $809,780 130 D
2025-09-15 Exercise or conversion : show line 5 in the form 10b5-1 +4,000 $120.26 $481,040 4,130 D
2025-09-15 Sale : show line 6 in the form 10b5-1 −2,540 $397.71 $1,010,180 1,590 D
2025-09-15 Sale : show line 7 in the form 10b5-1 −1,460 $398.19 $581,356 130 D
Open-market sales · 8,000 sh · avg $400.93 · $3,207,436

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-09-12 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option −4,000 $120.26 2026-03-15 4,000 274,000 D
2025-09-15 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option −4,000 $120.26 2026-03-15 4,000 270,000 D
Loading xslF345X05/tm2526183-1_4seq1.xml…